Your browser doesn't support javascript.
loading
Targeting TBK1 to overcome resistance to cancer immunotherapy.
Sun, Yi; Revach, Or-Yam; Anderson, Seth; Kessler, Emily A; Wolfe, Clara H; Jenney, Anne; Mills, Caitlin E; Robitschek, Emily J; Davis, Thomas G R; Kim, Sarah; Fu, Amina; Ma, Xiang; Gwee, Jia; Tiwari, Payal; Du, Peter P; Sindurakar, Princy; Tian, Jun; Mehta, Arnav; Schneider, Alexis M; Yizhak, Keren; Sade-Feldman, Moshe; LaSalle, Thomas; Sharova, Tatyana; Xie, Hongyan; Liu, Shuming; Michaud, William A; Saad-Beretta, Rodrigo; Yates, Kathleen B; Iracheta-Vellve, Arvin; Spetz, Johan K E; Qin, Xingping; Sarosiek, Kristopher A; Zhang, Gao; Kim, Jong Wook; Su, Mack Y; Cicerchia, Angelina M; Rasmussen, Martin Q; Klempner, Samuel J; Juric, Dejan; Pai, Sara I; Miller, David M; Giobbie-Hurder, Anita; Chen, Jonathan H; Pelka, Karin; Frederick, Dennie T; Stinson, Susanna; Ivanova, Elena; Aref, Amir R; Paweletz, Cloud P; Barbie, David A.
Afiliação
  • Sun Y; Massachusetts General Hospital Cancer Center, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
  • Revach OY; Massachusetts General Hospital Cancer Center, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
  • Anderson S; Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Kessler EA; Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Wolfe CH; Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Jenney A; Laboratory of Systems Pharmacology, Harvard Program in Therapeutic Sciences, Harvard Medical School, Boston, MA, USA.
  • Mills CE; Laboratory of Systems Pharmacology, Harvard Program in Therapeutic Sciences, Harvard Medical School, Boston, MA, USA.
  • Robitschek EJ; Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Davis TGR; Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Kim S; Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Fu A; Massachusetts General Hospital Cancer Center, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
  • Ma X; Massachusetts General Hospital Cancer Center, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
  • Gwee J; Massachusetts General Hospital Cancer Center, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
  • Tiwari P; Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Du PP; Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Sindurakar P; Massachusetts General Hospital Cancer Center, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
  • Tian J; Massachusetts General Hospital Cancer Center, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
  • Mehta A; Massachusetts General Hospital Cancer Center, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
  • Schneider AM; Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Yizhak K; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Sade-Feldman M; Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • LaSalle T; Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA.
  • Sharova T; Department of Cell Biology and Cancer Science, Rappaport Faculty of Medicine, Institute of Technology, Technion, Haifa, Israel.
  • Xie H; Massachusetts General Hospital Cancer Center, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
  • Liu S; Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Michaud WA; Massachusetts General Hospital Cancer Center, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
  • Saad-Beretta R; Division of Surgical Oncology, Department of Surgery, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA.
  • Yates KB; Massachusetts General Hospital Cancer Center, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
  • Iracheta-Vellve A; Laboratory of Systems Pharmacology, Harvard Program in Therapeutic Sciences, Harvard Medical School, Boston, MA, USA.
  • Spetz JKE; Division of Surgical Oncology, Department of Surgery, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA.
  • Qin X; Massachusetts General Hospital Cancer Center, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
  • Sarosiek KA; Massachusetts General Hospital Cancer Center, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
  • Zhang G; Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Kim JW; Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Su MY; Laboratory of Systems Pharmacology, Harvard Program in Therapeutic Sciences, Harvard Medical School, Boston, MA, USA.
  • Cicerchia AM; Molecular and Integrative Physiological Sciences Program, Harvard School of Public Health, Boston, MA, USA.
  • Rasmussen MQ; John B. Little Center for Radiation Sciences, Harvard School of Public Health, Boston, MA, USA.
  • Klempner SJ; Laboratory of Systems Pharmacology, Harvard Program in Therapeutic Sciences, Harvard Medical School, Boston, MA, USA.
  • Juric D; Molecular and Integrative Physiological Sciences Program, Harvard School of Public Health, Boston, MA, USA.
  • Pai SI; John B. Little Center for Radiation Sciences, Harvard School of Public Health, Boston, MA, USA.
  • Miller DM; Laboratory of Systems Pharmacology, Harvard Program in Therapeutic Sciences, Harvard Medical School, Boston, MA, USA.
  • Giobbie-Hurder A; Molecular and Integrative Physiological Sciences Program, Harvard School of Public Health, Boston, MA, USA.
  • Chen JH; John B. Little Center for Radiation Sciences, Harvard School of Public Health, Boston, MA, USA.
  • Pelka K; Molecular and Cellular Oncogenesis Program, The Wistar Institute, Philadelphia, PA, USA.
  • Frederick DT; Preston Robert Tisch Brain Tumor Center, Department of Neurosurgery, Duke University School of Medicine, Durham, NC, USA.
  • Stinson S; Preston Robert Tisch Brain Tumor Center, Department of Pathology, Duke University School of Medicine, Durham, NC, USA.
  • Ivanova E; Moores Cancer Center, UC San Diego, La Jolla, CA, USA.
  • Aref AR; Center for Novel Therapeutics, UC San Diego, La Jolla, CA, USA.
  • Paweletz CP; Department of Medicine, UC San Diego, La Jolla, CA, USA.
  • Barbie DA; Cutaneous Biology Research Center, Department of Dermatology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Nature ; 615(7950): 158-167, 2023 03.
Article em En | MEDLINE | ID: mdl-36634707
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas Serina-Treonina Quinases / Resistencia a Medicamentos Antineoplásicos / Evasão da Resposta Imune / Imunoterapia Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Nature Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas Serina-Treonina Quinases / Resistencia a Medicamentos Antineoplásicos / Evasão da Resposta Imune / Imunoterapia Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Nature Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Reino Unido